日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy

HER2靶向治疗期间减少心脏毒性监测的心脏安全性

Yu, Anthony F; Dang, Chau T; Moskowitz, Chaya S; Mishra Meza, Akriti; DeFusco, Patricia; Oligino, Eric; Chen, Carol L; Sanford, Rachel; Drullinsky, Pamela; Bromberg, Jacqueline; Wong, Serena; Modi, Shanu; Jorgensen, Justine; Oeffinger, Kevin C; Steingart, Richard M; Liu, Jennifer E

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma

外周T细胞淋巴瘤自体干细胞移植后罗米地辛维持治疗

Khan, Niloufer; Dahi, Parastoo B; Khimani, Farhad; Shustov, Andrei R; Shadman, Mazyar; Ruan, Jia; Moskowitz, Alison J; Zelenetz, Andrew D; Noy, Ariela; Straus, David J; Drullinsky, Pamela; Hamilton, Audrey; Kumar, Anita; Sauter, Craig S; Shah, Gunjan L; Matasar, Matthew J; Drill, Esther; Davey, Theresa; Hancock, Helen; Ganesan, Nivetha; Galasso, Natasha; van Beisen, Koen; Giralt, Sergio; Horwitz, Steven M

Program Evaluation of Acupuncture and Massage Services Delivered for Symptom Management at a Community Cancer Clinic

社区癌症诊所针灸和按摩服务在症状管理方面的项目评估

Booher, Allison G; Rico, Charles; Nouvini, Rosa; Killoran, Kathleen; Drullinsky, Pamela; Maxwell, Shaun; Li, Susan; Jutagir, Devika; McConnell, Kelly; Godfrey, Henry; Cadwell, Malik; Casaw, Camila; Rosa, William E; Muñiz, Rosario Costas; Liou, Kevin T

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

一项开放标签、随机、对照的II期研究,旨在评估标准全身治疗联合或不联合立体定向放射治疗对寡转移进展型乳腺癌或非小细胞肺癌患者的疗效(巩固性放射治疗阻断寡转移进展[CURB]):一项研究。

Tsai, Chiaojung Jillian; Yang, Jonathan T; Shaverdian, Narek; Patel, Juber; Shepherd, Annemarie F; Eng, Juliana; Guttmann, David; Yeh, Randy; Gelblum, Daphna Y; Namakydoust, Azadeh; Preeshagul, Isabel; Modi, Shanu; Seidman, Andrew; Traina, Tiffany; Drullinsky, Pamela; Flynn, Jessica; Zhang, Zhigang; Rimner, Andreas; Gillespie, Erin F; Gomez, Daniel R; Lee, Nancy Y; Berger, Michael; Robson, Mark E; Reis-Filho, Jorge S; Riaz, Nadeem; Rudin, Charles M; Powell, Simon N

Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation

免疫化疗联合来那度胺治疗高危套细胞淋巴瘤伴可测量残留病灶的评估

Epstein-Peterson, Zachary D; Drill, Esther; Aypar, Umut; Batlevi, Connie Lee; Caron, Philip; Dogan, Ahmet; Drullinsky, Pamela; Gerecitano, John; Hamlin, Paul A; Ho, Caleb; Jacob, Allison; Joseph, Ashlee; Laraque, Leana; Matasar, Matthew J; Moskowitz, Alison J; Moskowitz, Craig H; Mullins, Chelsea; Owens, Colette; Salles, Gilles; Schöder, Heiko; Straus, David J; Younes, Anas; Zelenetz, Andrew D; Kumar, Anita

Erratum to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation

更正:免疫化疗联合来那度胺治疗高危套细胞淋巴瘤伴可测量残留病灶评估

Epstein-Peterson, Zachary D; Drill, Esther; Aypar, Umut; Batlevi, Connie Lee; Caron, Philip; Dogan, Ahmet; Drullinsky, Pamela; Gerecitano, John; Hamlin, Paul A; Ho, Caleb; Jacob, Allison; Joseph, Ashlee; Laraque, Leana; Matasar, Matthew J; Moskowitz, Alison J; Moskowitz, Craig H; Mullins, Chelsea; Owens, Colette; Salles, Gilles; Schöder, Heiko; Straus, David J; Younes, Anas; Zelenetz, Andrew D; Kumar, Anita

Four-Dimensional Flow Magnetic Resonance Imaging Evaluation of Post-Ross David Procedure With Valve Repair

经四维流动磁共振成像评估Ross David手术后瓣膜修复

Thomae, Benjamin; Maroun, Anthony; Devlin, Paul; Drullinsky, David; Markl, Michael; Malaisrie, S Chris

Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome

林奇综合征患者乳腺癌的形态学和基因组学特征

Schwartz, Christopher J; da Silva, Edaise M; Marra, Antonio; Gazzo, Andrea M; Selenica, Pier; Rai, Vikas K; Mandelker, Diana; Pareja, Fresia; Misyura, Maksym; D'Alfonso, Timothy M; Brogi, Edi; Drullinsky, Pamela; Razavi, Pedram; Robson, Mark E; Drago, Joshua Z; Wen, Hannah Y; Zhang, Liying; Weigelt, Britta; Shia, Jinru; Reis-Filho, Jorge S; Zhang, Hong

Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

一项评估布帕利西布联合伊布替尼治疗套细胞淋巴瘤 (MCL)、滤泡性淋巴瘤 (FL) 和弥漫性大B细胞淋巴瘤 (DLBCL) 疗效和安全性的 I/Ib 期研究,并进行连续无细胞 DNA 监测

Stewart, Caitlin M; Michaud, Laure; Whiting, Karissa; Nakajima, Reiko; Nichols, Chelsea; De Frank, Stephanie; Hamlin, Paul A Jr; Matasar, Matthew J; Gerecitano, John F; Drullinsky, Pamela; Hamilton, Audrey; Straus, David; Horwitz, Steven M; Kumar, Anita; Moskowitz, Craig H; Moskowitz, Alison; Zelenetz, Andrew D; Rademaker, Jurgen; Salles, Gilles; Seshan, Venkatraman; Schöder, Heiko; Younes, Anas; Tsui, Dana W Y; Batlevi, Connie Lee

Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma

利妥昔单抗/泼尼松治疗前期治疗及老年脆弱患者体内与衰老相关的促炎细胞因子环境对新诊断弥漫性大B细胞淋巴瘤的影响

Lin, Richard J; Owens, Colette N; Drill, Esther; Iannotta, Augustine; Oliveros, Mayan; Schick, Dylan L; Noy, Ariela; Gerecitano, John F; Drullinsky, Pamela R; Caron, Philip C; Kumar, Anita; Matasar, Matthew J; Moskowitz, Craig; Korc-Grodzicki, Beatriz; Zelenetz, Andrew D; Salles, Gilles A; Hamlin, Paul A